Clinical and molecular features of mucosa-associated lymphoid tissue (MALT) lymphomas of salivary glands.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 19360750.
- Also identified by DOI 10.1002/hed.21087.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To analyze clinical features and to discuss the modality of investigation and treatment of a series of mucosa-associated lymphoid tissue (MALT) lymphomas. To investigate the prevalence of aberrant promoter methylation, responsible for gene inactivation, in a selected panel of genes potentially involved in the pathogenesis of B-cell malignancies as O6-methylguanine-DNA methyltransferase (MGMT), p73, death-associated protein kinase (DAP-k). Nine patients with primary MALT lymphoma of the salivary glands were retrospectively reviewed. MGMT, p73, DAP-k apoptotic pathways were tested. Methylation of DAP-k was common (5/8; 63%). Histological examination ensured diagnostic confirmation, whereas fine-needle aspiration cytology was not definitively diagnostic. Histological assessment is the gold standard in the diagnosis of salivary gland lesions. Parotidectomy represents a safe and reliable diagnostic tool leading to a definite diagnosis of MALT lymphomas in all cases and curative without other treatment in early-stage MALT lymphoma.
Medical subject headings
- Apoptosis Regulatory Proteins
- Calcium-Calmodulin-Dependent Protein Kinases
- DNA Modification Methylases
- DNA Repair Enzymes
- DNA-Binding Proteins
- Lymphoma, B-Cell, Marginal Zone
- Nuclear Proteins
- Salivary Gland Neoplasms
- Tumor Suppressor Proteins